Agreement Accelerates the Development of Tests to Help Assess Risk of Disease Recurrence in Women with Early-Stage Breast Cancer SANTA CLARA, Calif. & IRVINE, Calif.–Agilent Technologies Inc. (NYSE: A) and Agendia, Inc. today jointly announced an agreement to expand their relationship to include the development of an RNA-Seq kit version of Agendia’s currently marketed MammaPrint […]
Omaha, NE – Streck, Inc. and Nordic BioSite, a life sciences products distributor in Sweden, Finland, Denmark and Norway, have signed a distribution agreement for Streck’s full portfolio of cell stabilization, molecular and core products. Streck’s cell stabilization products include Cell-Free DNA Urine Preserve, a formaldehyde-free liquid reagent that stabilizes cell-free DNA (cfDNA) in urine; […]
PORTLAND, OR and CAMBRIDGE, MA— MolecularMD Corp., a molecular diagnostics company that provides clinical trial services and development of companion diagnostics for targeted and immunotherapies in oncology, is now recognized as a Certified Service Provider of ArcherDX next-generation sequencing (NGS) panels, adding to MolecularMD’s NGS Advanced Diagnostics service offering. The agreement solidifies MolecularMD as a […]
The National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC) has become the newest member of the Panorama Partners Program. SEATTLE, WA LabKey is pleased to announce that the National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC) has become the newest member of the Panorama Partners Program, a collaboration of proteomics focused […]
Newton, NJ – Thorlabs is pleased to announce the establishment of PolySense, a joint industry-university research lab in the physics department at the Technical University in Bari, Italy, to focus on the research and development of innovative optical gas sensing systems. The move augments Thorlabs’ current research collaborations with Vincenzo Spagnolo, an expert in optical gas […]
Waters Corporation (NYSE:WAT) and Andrew Alliance today announced they have signed an agreement that will bring drug development scientists an easy-to-use, semi-automated sample preparation approach for released N-glycan profiling and analysis by LC and LC-MS. Under the co-marketing agreement, Waters will combine its existing Glycoworks™ RapiFluor-MS™ (RFMS) N-Glycan Kits with an Andrew pipetting robot that […]
Waters Corporation has announced a collaborative engagement with IonSense to interface the compact Waters® ACQUITY® QDa® Mass Detector with the IonSense® DART® ionization source. The combination of the two products will enable the rapid generation of mass data directly from liquid or solid samples with little or no sample preparation and is expected to be […]
(Berlin.) JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, is pleased to announce a new demonstration capability at their Berlin headquarters. In collaboration with Abberior Instruments, visitors to JPK’s applications facility will be able to see STED capability demonstrated in conjunction with the NanoWizard® AFMs. Following collaboration […]
PRINCETON, NJ – Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that it is partnering with Phase I Unit, Peking Union Medical College (PUMC) Hospital’s Clinical Pharmacology Research Center (PUMCH-CPRC) in Beijing to help Chinese pharmaceutical companies enhance their drug development processes. Phase […]
Cole-Parmer Ltd, a leading UK manufacturer of analytical laboratory instruments, announced today that Stuart equipment is being used by Guy’s and St Thomas’ NHS Foundation Trust, located in London, to improve epidural anaesthesia. The Department of Obstetric Anaesthesia at Guy’s and St Thomas’ NHS Trust selected Stuart’s water bath equipment due to its internationally renowned […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
